Format

Send to

Choose Destination
Cell Death Dis. 2017 Jan 12;8(1):e2554. doi: 10.1038/cddis.2016.488.

Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.

Author information

1
Personalized Genomic Medicine Research Center, KRIBB, Daejeon 305-806, Korea.
2
Functional Genomics, University of Science and Technology, Daejeon 305-701, Korea.
3
Metabolic Regulation Research Center, KRIBB, Daejeon 305-806, Korea.
4
Oligo Team, ST Pharm. Co., LTD, Sihwa Industrial Complex 1, Kyunggido 429-848, Korea.

Abstract

DNA damage-induced apoptosis suppressor (DDIAS) rescues lung cancer cells from apoptosis in response to DNA damage. DDIAS is transcriptionally activated by NFATc1 and EGF-mediated ERK5/MEF2B, leading to cisplatin resistance and cell invasion. Therefore, DDIAS is suggested as a therapeutic target for lung cancer. Here, we report that DDIAS stability is regulated by E3 U-box ubiquitin ligase carboxyl terminus of HSP70-interacting protein (CHIP)-mediated proteasomal degradation. We first isolated CHIP as an interacting partner of DDIAS by yeast two-hybrid screening. CHIP physically associated with both the N- and C-terminal regions of DDIAS, targeting it for proteasomal degradation and reducing the DDIAS half-life. CHIP overexpression analyses indicated that the tetratrico peptide repeat (TPR) domain and the U-box are required for DDIAS ubiquitination. It is likely that HSP70-bound DDIAS is recruited to the CHIP E3 ligase via the TPR domain, suggesting DDIAS as a client protein of HSP70. In addition, CHIP overexpression in lung cancer cells expressing high DDIAS levels induced significant growth inhibition by enhancing DDIAS degradation. Furthermore, simultaneous CHIP overexpression and DNA damage agent treatment caused a substantial increase in the apoptosis of lung cancer cells. Taken together, these findings indicate that the stability of the DDIAS protein is regulated by CHIP/HSP70-mediated proteasomal degradation and that CHIP overexpression stimulates the apoptosis of lung cancer cells in response to DNA-damaging agents.

PMID:
28079882
PMCID:
PMC5386388
DOI:
10.1038/cddis.2016.488
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center